398 related articles for article (PubMed ID: 29756667)
1. Soluble Fgl2 restricts autoimmune hepatitis progression via suppressing Tc17 and conventional CD8+ T cell function.
Ai G; Yan W; Yu H; Xiao F; Xi D; Ma K; Huang J; Luo X; Wan X; Ning Q
J Gene Med; 2018 Jul; 20(7-8):e3023. PubMed ID: 29756667
[TBL] [Abstract][Full Text] [Related]
2. sFgl2 gene-modified MSCs regulate the differentiation of CD4
Ji W; Wang W; Li P; Liu Y; Zhang B; Qi F
Stem Cell Res Ther; 2023 Nov; 14(1):316. PubMed ID: 37924141
[TBL] [Abstract][Full Text] [Related]
3. The Imbalance between Foxp3
Liang M; Liwen Z; Yun Z; Yanbo D; Jianping C
J Immunol Res; 2018; 2018():3753081. PubMed ID: 30050955
[TBL] [Abstract][Full Text] [Related]
4. Soluble fibrinogen-like protein 2 promotes the growth of hepatocellular carcinoma via attenuating dendritic cell-mediated cytotoxic T cell activity.
Yang M; Zhang Z; Chen J; Xu M; Huang J; Wang M; Li W; Wan X; Yuen MF; Luo X; Xi D; Ning Q
J Exp Clin Cancer Res; 2019 Aug; 38(1):351. PubMed ID: 31409352
[TBL] [Abstract][Full Text] [Related]
5. Fatal autoimmune hepatitis induced by concurrent loss of naturally arising regulatory T cells and PD-1-mediated signaling.
Kido M; Watanabe N; Okazaki T; Akamatsu T; Tanaka J; Saga K; Nishio A; Honjo T; Chiba T
Gastroenterology; 2008 Oct; 135(4):1333-43. PubMed ID: 18651994
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory function of Tregs via soluble FGL2 in chronic hepatitis B.
Xu L; Yang D; Liu Y; Wu D; Wang X; Ning Q
J Huazhong Univ Sci Technolog Med Sci; 2012 Aug; 32(4):540-545. PubMed ID: 22886967
[TBL] [Abstract][Full Text] [Related]
7. FOXP3+ regulatory T cells in autoimmune hepatitis are fully functional and not reduced in frequency.
Peiseler M; Sebode M; Franke B; Wortmann F; Schwinge D; Quaas A; Baron U; Olek S; Wiegard C; Lohse AW; Weiler-Normann C; Schramm C; Herkel J
J Hepatol; 2012 Jul; 57(1):125-32. PubMed ID: 22425700
[TBL] [Abstract][Full Text] [Related]
8. Intrahepatic regulatory T cells in autoimmune hepatitis are associated with treatment response and depleted with current therapies.
Taubert R; Hardtke-Wolenski M; Noyan F; Wilms A; Baumann AK; Schlue J; Olek S; Falk CS; Manns MP; Jaeckel E
J Hepatol; 2014 Nov; 61(5):1106-14. PubMed ID: 24882050
[TBL] [Abstract][Full Text] [Related]
9. Assessment of intrahepatic regulatory T cells in children with autoimmune hepatitis.
Behairy BE; El-Araby HA; Abd El Kader HH; Ehsan NA; Salem ME; Zakaria HM; Khedr MA
Ann Hepatol; 2016; 15(5):682-90. PubMed ID: 27493106
[TBL] [Abstract][Full Text] [Related]
10. Adoptive transfer of regulatory T cells stimulated by Allogeneic Hepatic Stellate Cells mitigates liver injury in mice with concanavalin A-induced autoimmune hepatitis.
Huang H; Deng Z
Biochem Biophys Res Commun; 2019 Apr; 512(1):14-21. PubMed ID: 30853178
[TBL] [Abstract][Full Text] [Related]
11. Treg-specific IL-2 therapy can reestablish intrahepatic immune regulation in autoimmune hepatitis.
Buitrago-Molina LE; Pietrek J; Noyan F; Schlue J; Manns MP; Wedemeyer H; Hardtke-Wolenski M; Jaeckel E
J Autoimmun; 2021 Feb; 117():102591. PubMed ID: 33387980
[TBL] [Abstract][Full Text] [Related]
12. Hepatocytes paradoxically affect intrahepatic IFN-γ production in autoimmune hepatitis due to Gal-9 expression and TLR2/4 ligand release.
Mo R; Feng XX; Wu YN; Wang H; He YP; Sun HH; Guo F; Chen Q; Yan W; Li PY; Liu M; Zhang GM; Tian DA; Feng ZH
Mol Immunol; 2020 Jul; 123():106-115. PubMed ID: 32485469
[TBL] [Abstract][Full Text] [Related]
13. Altered aryl-hydrocarbon-receptor signalling affects regulatory and effector cell immunity in autoimmune hepatitis.
Vuerich M; Harshe R; Frank LA; Mukherjee S; Gromova B; Csizmadia E; Nasser IAM; Ma Y; Bonder A; Patwardhan V; Robson SC; Longhi MS
J Hepatol; 2021 Jan; 74(1):48-57. PubMed ID: 32663496
[TBL] [Abstract][Full Text] [Related]
14. Foxp3⁺ Treg Cells Are Associated with Pathological Process of Autoimmune Hepatitis by Activating Methylation Modification in Autoimmune Hepatitis Patients.
Chen J; Liu W; Zhu W
Med Sci Monit; 2019 Aug; 25():6204-6212. PubMed ID: 31422415
[TBL] [Abstract][Full Text] [Related]
15. Soluble fibrinogen like protein 2 (sFGL2), the novel effector molecule for immunoregulation.
Liu XG; Liu Y; Chen F
Oncotarget; 2017 Jan; 8(2):3711-3723. PubMed ID: 27732962
[TBL] [Abstract][Full Text] [Related]
16. Effects and regulation of autoreactive CD8+ T cells in a transgenic mouse model of autoimmune hepatitis.
Zierden M; Kühnen E; Odenthal M; Dienes HP
Gastroenterology; 2010 Sep; 139(3):975-86, 986.e1-3. PubMed ID: 20639127
[TBL] [Abstract][Full Text] [Related]
17. The induction of autoimmune hepatitis in the human leucocyte antigen-DR4 non-obese diabetic mice autoimmune hepatitis mouse model.
Yuksel M; Xiao X; Tai N; Vijay M; Gülden E; Beland K; Lapierre P; Alvarez F; Hu Z; Colle I; Ma Y; Wen L
Clin Exp Immunol; 2016 Nov; 186(2):164-176. PubMed ID: 27414259
[TBL] [Abstract][Full Text] [Related]
18. Soluble fibrinogen-like protein 2 levels in patients with hepatitis B virus-related liver diseases.
Van Tong H; Van Ba N; Hoan NX; Binh MT; Quyen DT; Son HA; Van Luong H; Quyet D; Meyer CG; Song LH; Toan NL; Velavan TP
BMC Infect Dis; 2018 Nov; 18(1):553. PubMed ID: 30419833
[TBL] [Abstract][Full Text] [Related]
19. Pediatric autoimmune hepatitis shows a disproportionate decline of regulatory T cells in the liver and of IL-2 in the blood of patients undergoing therapy.
Diestelhorst J; Junge N; Schlue J; Falk CS; Manns MP; Baumann U; Jaeckel E; Taubert R
PLoS One; 2017; 12(7):e0181107. PubMed ID: 28700730
[TBL] [Abstract][Full Text] [Related]
20. Erythropoietin administration expands regulatory T cells in patients with autoimmune hepatitis.
McEachern E; Carroll AM; Fribourg M; Schiano TD; Hartzell S; Bin S; Cravedi P; Levitsky J
J Autoimmun; 2021 May; 119():102629. PubMed ID: 33721837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
